000813 德展健康
已收盘 02-06 15:00:00
资讯
新帖
简况
股市必读：德展健康（000813）预计2025年全年扣非后净利润亏损1.75亿元至3.5亿元
证券之星 · 02-02
股市必读：德展健康（000813）预计2025年全年扣非后净利润亏损1.75亿元至3.5亿元
德展健康（000813）披露2025年度业绩预告，预计净亏损1.75亿元至3.5亿元，1月30日股价上涨3.36%
证券之星 · 01-30
德展健康（000813）披露2025年度业绩预告，预计净亏损1.75亿元至3.5亿元，1月30日股价上涨3.36%
德展健康（000813）披露2025年第三次临时股东会决议公告，12月31日股价下跌0.52%
证券之星 · 2025-12-31
德展健康（000813）披露2025年第三次临时股东会决议公告，12月31日股价下跌0.52%
德展健康：持有东方略22.70%股份采用权益法核算
证券之星 · 2025-12-03
德展健康：持有东方略22.70%股份采用权益法核算
德展健康：海南德澄国际医康养综合体项目部分建筑主体已封顶
证券之星 · 2025-12-03
德展健康：海南德澄国际医康养综合体项目部分建筑主体已封顶
德展健康（000813）披露关于公司诉讼事项的进展公告，11月26日股价下跌0.24%
证券之星 · 2025-11-26
德展健康（000813）披露关于公司诉讼事项的进展公告，11月26日股价下跌0.24%
股市必读：德展健康（000813）11月18日董秘有最新回复
证券之星 · 2025-11-20
股市必读：德展健康（000813）11月18日董秘有最新回复
股市必读：德展健康(000813)股东户数5.76万户，较上期减少1.13%
证券之星 · 2025-10-27
股市必读：德展健康(000813)股东户数5.76万户，较上期减少1.13%
德展健康（000813）披露公司2025年第三季度报告，10月24日股价下跌1.88%
证券之星 · 2025-10-24
德展健康（000813）披露公司2025年第三季度报告，10月24日股价下跌1.88%
德展健康：海南德澄国际医康养综合体项目将充分利用自贸港政策与资源优势
证券之星 · 2025-10-15
德展健康：海南德澄国际医康养综合体项目将充分利用自贸港政策与资源优势
德展健康（000813）发布选举董事长及聘任高级管理人员公告，9月16日股价上涨0.42%
证券之星 · 2025-09-16
德展健康（000813）发布选举董事长及聘任高级管理人员公告，9月16日股价上涨0.42%
异动快报：德展健康（000813）9月1日11点9分触及涨停板
证券之星 · 2025-09-01
异动快报：德展健康（000813）9月1日11点9分触及涨停板
德展健康：公司持有东方略股份比例22.70%为其第一大股东
证券之星 · 2025-08-29
德展健康：公司持有东方略股份比例22.70%为其第一大股东
德展健康：VGX-3100国内Ⅲ期临床试验已完成全部患者入组
证券之星 · 2025-08-29
德展健康：VGX-3100国内Ⅲ期临床试验已完成全部患者入组
德展健康(000813)6月30日股东户数5.83万户，较上期减少10.9%
证券之星 · 2025-08-23
德展健康(000813)6月30日股东户数5.83万户，较上期减少10.9%
图解德展健康中报：第二季度单季净利润同比下降177.20%
证券之星 · 2025-08-23
图解德展健康中报：第二季度单季净利润同比下降177.20%
德展健康(000813.SZ)已累计回购1.32%股份 耗资约7326.59万元
智通财经 · 2025-03-03
德展健康(000813.SZ)已累计回购1.32%股份 耗资约7326.59万元
德展健康：2月28日接受机构调研，远惟投资、德源资本等多家机构参与
证券之星 · 2025-02-28
德展健康：2月28日接受机构调研，远惟投资、德源资本等多家机构参与
德展健康收盘上涨3.88%，滚动市盈率250.81倍，总市值75.34亿元
金融界 · 2025-02-20
德展健康收盘上涨3.88%，滚动市盈率250.81倍，总市值75.34亿元
加载更多
公司概况
公司名称：
德展大健康股份有限公司
所属行业：
医药制造业
上市日期：
1998-05-19
主营业务：
德展大健康股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是阿托伐他汀钙片（阿乐）、氨氯地平阿托伐他汀钙片（尼乐）、华法林钠片、盐酸曲美他嗪胶囊/盐酸曲美他嗪片（奉乐）、盐酸胺碘酮片、泛昔洛韦片（凡乐）、硫唑嘌呤片、羟基脲片和秋水仙碱片。
发行价格：
4.57
{"stockData":{"symbol":"000813","market":"SZ","secType":"STK","nameCN":"德展健康","latestPrice":3.94,"timestamp":1770361401000,"preClose":3.95,"halted":0,"volume":43092138,"delay":0,"changeRate":-0.0025,"floatShares":2097000000,"shares":2097000000,"eps":-0.0427,"marketStatus":"已收盘","change":-0.01,"latestTime":"02-06 15:00:00","open":3.94,"high":4.05,"low":3.91,"amount":172000000,"amplitude":0.0354,"askPrice":3.95,"askSize":2555,"bidPrice":3.94,"bidSize":7168,"shortable":0,"etf":0,"ttmEps":-0.0427,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.95,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":4.35,"lowLimit":3.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2097105540,"isCdr":false,"pbRate":1.66,"roa":"--","roe":"--","epsLYR":-0.0095,"committee":0.370788,"marketValue":8263000000,"turnoverRate":0.0206,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-02-09。","floatMarketCap":8261000000},"requestUrl":"/m/hq/s/000813","defaultTab":"news","newsList":[{"id":"2608885754","title":"股市必读：德展健康（000813）预计2025年全年扣非后净利润亏损1.75亿元至3.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608885754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608885754?lang=zh_cn&edition=full","pubTime":"2026-02-02 01:44","pubTimestamp":1769967854,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，德展健康报收于4.31元，上涨3.36%，换手率9.31%，成交量195.18万手，成交额8.52亿元。交易信息汇总资金流向1月30日主力资金净流出2766.85万元；游资资金净流出2030.99万元；散户资金净流入4797.84万元。业绩披露要点业绩预告德展健康发布业绩预告，预计2025年全年扣非后净利润亏损1.75亿元至3.5亿元。公司公告汇总2025年度业绩预告德展大健康股份有限公司预计2025年度归属于上市公司股东的净利润亏损17,500.00万元至35,000.00万元，上年同期为亏损2,041.31万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200000804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"gpt_icon":0},{"id":"2607413740","title":"德展健康（000813）披露2025年度业绩预告，预计净亏损1.75亿元至3.5亿元，1月30日股价上涨3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607413740","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607413740?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:25","pubTimestamp":1769783120,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，德展健康报收于4.31元，较前一交易日上涨3.36%，最新总市值为90.39亿元。该股当日开盘4.52元，最高4.52元，最低4.22元，成交额达8.52亿元，换手率为9.31%。近日，德展大健康股份有限公司披露《2025年度业绩预告》。公告显示，公司预计2025年度归属于上市公司股东的净利润亏损17,500.00万元至35,000.00万元，上年同期为亏损2,041.31万元；扣除非经常性损益后的净利润同样预计亏损17,500.00万元至35,000.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","000813","BK0060","BK0239"],"gpt_icon":0},{"id":"2595442720","title":"德展健康（000813）披露2025年第三次临时股东会决议公告，12月31日股价下跌0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595442720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595442720?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:43","pubTimestamp":1767174183,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，德展健康报收于3.84元，较前一交易日下跌0.52%，最新总市值为80.53亿元。该股当日开盘3.86元，最高3.87元，最低3.81元，成交额达7291.17万元，换手率为0.91%。公司近日发布公告称，德展健康于2025年12月30日召开2025年第三次临时股东会，审议通过了制定公司董事津贴方案、修订多项治理制度、废止部分治理制度以及聘任年审会计师事务所等议案。所有议案均获通过，表决结果符合法定要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100032496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","000813","BK0060","BK0239"],"gpt_icon":0},{"id":"2588049046","title":"德展健康：持有东方略22.70%股份采用权益法核算","url":"https://stock-news.laohu8.com/highlight/detail?id=2588049046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588049046?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:54","pubTimestamp":1764766470,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康(000813)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司对子公司东方略的长期股权投资是成本法还是权益法核算？德展健康回复：尊敬的投资者您好，公司持有东方略股份比例22.70%，对其采用权益法核算。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813","BK0060","BK0114","BK0239"],"gpt_icon":0},{"id":"2588046048","title":"德展健康：海南德澄国际医康养综合体项目部分建筑主体已封顶","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588046048?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:54","pubTimestamp":1764766469,"startTime":"0","endTime":"0","summary":"目前该项目部分建筑物主体结构已封顶，作为海南区域内项目享有海南自由贸易港的普惠性政策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813","BK0060","BK0114","BK0239"],"gpt_icon":0},{"id":"2586585592","title":"德展健康（000813）披露关于公司诉讼事项的进展公告，11月26日股价下跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586585592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586585592?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:51","pubTimestamp":1764150711,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，德展健康报收于4.15元，较前一交易日下跌0.24%，最新总市值为87.03亿元。该股当日开盘4.16元，最高4.32元，最低4.13元，成交额达2.16亿元，换手率为2.44%。公司近日发布公告称，于2025年11月24日收到北京市高级人民法院京民终500号《民事裁定书》。因北京华新与公司原控股股东关联方合同纠纷案，北京高院裁定撤销北京三中院驳回起诉的原裁定，指令北京三中院重新审理。公司表示将积极应诉并依法维护股东利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000813","BK0114"],"gpt_icon":0},{"id":"2584927452","title":"股市必读：德展健康（000813）11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584927452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584927452?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:55","pubTimestamp":1763574917,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，德展健康报收于4.4元，下跌2.87%，换手率2.47%，成交量51.75万手，成交额2.3亿元。董秘最新回复投资者： 请问公司截至10月31日的股东人数是多少，谢谢董秘： 尊敬的投资者您好，股东人数相关信息请见公司定期报告。交易信息汇总资金流向11月18日主力资金净流入117.75万元，占总成交额0.51%；游资资金净流入886.51万元，占总成交额3.85%；散户资金净流出1004.26万元，占总成交额4.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","000813","BK0060"],"gpt_icon":0},{"id":"2578656449","title":"股市必读：德展健康(000813)股东户数5.76万户，较上期减少1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578656449","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578656449?lang=zh_cn&edition=full","pubTime":"2025-10-27 00:48","pubTimestamp":1761497293,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，德展健康报收于4.17元，下跌1.88%，换手率2.36%，成交量49.57万手，成交额2.08亿元。来自公司公告汇总：德展健康第九届董事会第二次会议审议通过《关于公司2025年第三季度报告的议案》，无反对或弃权票。股本股东变化股东户数变动截至2025年9月30日，德展健康股东户数为5.76万户，较6月30日减少656.0户，减幅1.13%。户均持股数量由上期的3.72万股降至3.64万股，户均持股市值为15.98万元。公告日期为2025年10月25日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700000240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","BK0060","000813"],"gpt_icon":0},{"id":"2577230512","title":"德展健康（000813）披露公司2025年第三季度报告，10月24日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577230512","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577230512?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:03","pubTimestamp":1761314598,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，德展健康报收于4.17元，较前一交易日下跌1.88%，最新总市值为87.45亿元。该股当日开盘4.23元，最高4.26元，最低4.15元，成交额达2.08亿元，换手率为2.36%。近日，德展大健康股份有限公司召开第九届董事会第二次会议，审议通过《关于公司2025年第三季度报告的议案》。该议案已获公司审计委员会审议通过。公司2025年第三季度报告的具体内容已在《证券时报》《上海证券报》《中国证券报》《证券日报》及巨潮资讯网披露，公告编号为2025-072。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400042130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0114","000813","BK0060"],"gpt_icon":0},{"id":"2575222538","title":"德展健康：海南德澄国际医康养综合体项目将充分利用自贸港政策与资源优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2575222538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575222538?lang=zh_cn&edition=full","pubTime":"2025-10-15 09:01","pubTimestamp":1760490069,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康(000813)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，近期公布的海南封关时间确定对公司海南康养中心项目有什么影响？德展健康回复：尊敬的投资者您好，公司高度重视海南自贸港建设带来的发展机遇，并密切关注相关政策动向。公司海南德澄国际医康养综合体项目作为海南省2025年重大项目，将充分利用海南自贸港政策与资源优势，积极研究和评估政策对项目的影响，挖掘潜在的发展机遇。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500006690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399319","000813","BK0060","BK0114"],"gpt_icon":0},{"id":"2567486182","title":"德展健康（000813）发布选举董事长及聘任高级管理人员公告，9月16日股价上涨0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567486182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567486182?lang=zh_cn&edition=full","pubTime":"2025-09-16 22:22","pubTimestamp":1758032545,"startTime":"0","endTime":"0","summary":"截至2025年9月16日收盘，德展健康报收于4.74元，较前一交易日上涨0.42%，最新总市值为99.4亿元。近日，德展大健康股份有限公司发布关于选举董事长、联席董事长及聘任高级管理人员、证券事务代表等事项的公告。公司于2025年9月16日召开第九届董事会第一次会议，选举魏哲明为董事长，刘伟为联席董事长。上述人员任期均为三年，与第九届董事会任期一致。相关人员简历及联系方式已公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600038176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","000813","BK0114"],"gpt_icon":0},{"id":"2564386732","title":"异动快报：德展健康（000813）9月1日11点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2564386732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564386732?lang=zh_cn&edition=full","pubTime":"2025-09-01 11:10","pubTimestamp":1756696238,"startTime":"0","endTime":"0","summary":"证券之星9月1日盘中消息，11点9分德展健康触及涨停板。目前价格4.18，上涨10.0%。其所属行业化学制药目前上涨。领涨股为迈威生物。该股为减肥药，创新药，疫苗概念热股，当日减肥药概念上涨2.93%，创新药概念上涨2.78%，疫苗概念上涨2.43%。8月29日的资金流向数据方面，主力资金净流出746.87万元，占总成交额3.38%，游资资金净流入673.77万元，占总成交额3.05%，散户资金净流入73.1万元，占总成交额0.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100008909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0114","000813"],"gpt_icon":0},{"id":"2563195092","title":"德展健康：公司持有东方略股份比例22.70%为其第一大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2563195092","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563195092?lang=zh_cn&edition=full","pubTime":"2025-08-29 11:33","pubTimestamp":1756438400,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康08月28日在投资者关系平台上答复投资者关心的问题。，东方略生物的VGX-3100宫颈癌药物在国外三期临床已经完成？德展健康回复：尊敬的投资者您好，公司持有东方略股份比例22.70%，为其第一大股东。东方略现任董事长为仇思念先生，其在研重点产品VGX-3100的首个适应症国内Ⅲ期临床试验已完成全部患者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900017581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","000813","BK0060","BK0239"],"gpt_icon":0},{"id":"2563092433","title":"德展健康：VGX-3100国内Ⅲ期临床试验已完成全部患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2563092433","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563092433?lang=zh_cn&edition=full","pubTime":"2025-08-29 11:33","pubTimestamp":1756438396,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康(000813)08月28日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好：参股公司东方略生物 VGX-3100 宫颈癌前病变中国三期临床试验，完成全部受试者入组？德展健康回复：尊敬的投资者您好，公司参股公司东方略在研重点产品VGX-3100的首个适应症（用于HPV-16和/或HPV-18相关的宫颈高级别癌前病变的治疗）国内Ⅲ期临床试验已完成全部患者入组。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900017578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0239","BK0060","000813"],"gpt_icon":0},{"id":"2561235249","title":"德展健康(000813)6月30日股东户数5.83万户，较上期减少10.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561235249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561235249?lang=zh_cn&edition=full","pubTime":"2025-08-23 17:04","pubTimestamp":1755939895,"startTime":"0","endTime":"0","summary":"证券之星消息，近日德展健康披露，截至2025年6月30日公司股东户数为5.83万户，较3月31日减少7124.0户，减幅为10.9%。在化学制药行业个股中，德展健康股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.28万户。从股价来看，2025年3月31日至2025年6月30日，德展健康区间跌幅为2.72%，在此期间股东户数减少7124.0户，减幅为10.9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082300016429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0114","BK0239","000813"],"gpt_icon":0},{"id":"2561449404","title":"图解德展健康中报：第二季度单季净利润同比下降177.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561449404","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561449404?lang=zh_cn&edition=full","pubTime":"2025-08-23 01:57","pubTimestamp":1755885471,"startTime":"0","endTime":"0","summary":"证券之星消息，德展健康2025年中报显示，公司主营收入1.66亿元，同比下降33.01%；归母净利润-4292.65万元，同比下降522.81%；扣非净利润-4549.32万元，同比下降675.71%；其中2025年第二季度，公司单季度主营收入7707.84万元，同比下降47.59%；单季度归母净利润-2081.16万元，同比下降177.2%；单季度扣非净利润-2159.13万元，同比下降183.68%；负债率4.97%，投资收益-1023.89万元，财务费用-2531.88万元，毛利率54.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082300001810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000813"],"gpt_icon":0},{"id":"2516507481","title":"德展健康(000813.SZ)已累计回购1.32%股份 耗资约7326.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516507481","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516507481?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:46","pubTimestamp":1740991609,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德展健康(000813.SZ)发布公告，截至2025年2月28日，公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份2856.75万股，占公司目前总股本的1.32%，最高成交价为3.21元/股，最低成交价为2.39元/股，成交总金额7326.59万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000813","BK0060","BK0114","BK0239"],"gpt_icon":0},{"id":"2514320952","title":"德展健康：2月28日接受机构调研，远惟投资、德源资本等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320952","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320952?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753089,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年2月28日德展健康发布公告称公司于2025年2月28日接受机构调研，远惟投资张翠双、德源资本徐志夫、嘉期九楹投资金珂、风炎投资王鹏、磊垚资本李晖、兴业银行刘溢、钛资本郭丹丹参与。公司2024年年度报告计划于2025年4月25日发布，全年业绩情况请关注公司定期报告。德展健康主营业务：药品的研发、生产和销售。融资融券数据显示该股近3个月融资净流入6347.86万，融资余额增加；融券净流入66.64万，融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800046314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000813","BK0114","BK0060"],"gpt_icon":0},{"id":"2512418807","title":"德展健康收盘上涨3.88%，滚动市盈率250.81倍，总市值75.34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512418807","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512418807?lang=zh_cn&edition=full","pubTime":"2025-02-20 16:09","pubTimestamp":1740038947,"startTime":"0","endTime":"0","summary":"2月20日，德展健康今日收盘3.48元，上涨3.88%，滚动市盈率PE达到250.81倍，总市值75.34亿元。股东方面，截至2024年9月30日，德展健康股东户数51038户，较上次增加3户，户均持股市值35.28万元，户均持股数量2.76万股。2019年度，公司入选“中国上市企业市值500强”。公司子公司嘉林药业现跻身中国制药工业百强前50名，多次荣获中国化学制药行业工业企业综合实力百强称号，荣获北京市诚信创业企业、行业领军企业等荣誉。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/20160948278993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000813","BK0060","BK0114","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770538489357,"stockEarnings":[{"period":"1week","weight":-0.0858},{"period":"1month","weight":0.0103},{"period":"3month","weight":-0.1146},{"period":"6month","weight":-0.0597},{"period":"1year","weight":0.2751},{"period":"ytd","weight":0.026}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"德展大健康股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"57596人(较上一季度减少1.13%)","perCapita":"36404股","listingDate":"1998-05-19","address":"新疆维吾尔自治区乌鲁木齐市天山区金银路53号金融大厦1611室","registeredCapital":"209710万元","survey":" 德展大健康股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是阿托伐他汀钙片（阿乐）、氨氯地平阿托伐他汀钙片（尼乐）、华法林钠片、盐酸曲美他嗪胶囊/盐酸曲美他嗪片（奉乐）、盐酸胺碘酮片、泛昔洛韦片（凡乐）、硫唑嘌呤片、羟基脲片和秋水仙碱片。","listedPrice":4.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德展健康(000813)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德展健康(000813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德展健康,000813,德展健康股票,德展健康股票老虎,德展健康股票老虎国际,德展健康行情,德展健康股票行情,德展健康股价,德展健康股市,德展健康股票价格,德展健康股票交易,德展健康股票购买,德展健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德展健康(000813)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德展健康(000813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}